Literature DB >> 28076916

False positive hepatitis B virus core and surface antibodies due to intravenous immunoglobulin.

Nicola Benwell1, Peter Boan2, Edward Raby2, Ben McGettigan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28076916     DOI： 10.1111/imj.13314

Source DB:  PubMed          Journal:  Intern Med J        ISSN： 1444-0903            Impact factor:   2.048


× No keyword cloud information.
  4 in total

1.  Passive transfer of anti-HBc after intravenous immunoglobulin administration in patients with cancer: a retrospective chart review.

Authors:  Huifang Lu; Anna S Lok; Carla L Warneke; Sairah Ahmed; Harrys A Torres; Fernando Martinez; Maria E Suarez-Almazor; Jessica T Foreman; Alessandra Ferrajoli; Jessica P Hwang
Journal:  Lancet Haematol       Date:  2018-10       Impact factor: 18.959

2.  Assessing Hepatitis B Reactivation Risk With Rituximab and Recent Intravenous Immunoglobulin Therapy.

Authors:  Claire Dysart; Karine Rozenberg-Ben-Dror; Mariscelle Sales
Journal:  Open Forum Infect Dis       Date:  2020-03-02       Impact factor: 3.835

3.  Misleading hepatitis B serology following Rho (D) immune globulin (human) injection and influenza vaccine.

Authors:  Xuanxuan Chen
Journal:  Clin Pract       Date:  2018-03-21

Review 4.  Adverse Effects of Immunoglobulin Therapy.

Authors:  Yi Guo; Xin Tian; Xuefeng Wang; Zheng Xiao
Journal:  Front Immunol       Date:  2018-06-08       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.